Glucotrack Inc (GCTK) Stock Price, Quote & News

Company Profile

GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a non-invasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It is also developing the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 201 842 7715

Website: glucotrack.com

Address:

301 Route 17 North, Suite 800, Rutherford, United States

race2zero Feb. 4 at 5:29 AM

$GCTK did you give up?

0 · Reply

race2zero Feb. 3 at 9:03 PM

$GCTK just a reminder people. Down 99.99% all time, picture perfect bio scam company with no future

0 · Reply

race2zero Feb. 3 at 8:58 PM

$GCTK better tell them to release the news, it’s headed under $1 if they don’t

0 · Reply

race2zero Feb. 3 at 7:31 PM

$GCTK all the bulls are gone!

0 · Reply

SorinC Feb. 3 at 7:23 PM

$GCTK where's this guy?told him he's an idiot and didn't believe me🤣 @JesseBullman

0 · Reply

PLATINUM_TRADES Feb. 3 at 6:41 PM

$GCTK Adds! Over $2.00 soon imo be patient 🚨🚨

0 · Reply

race2zero Feb. 3 at 5:12 PM

$GCTK seems to be going the wrong direction, again…

0 · Reply

race2zero Feb. 3 at 2:45 PM

$GCTK lots of green out there today and then there’s this…

1 · Reply

race2zero Feb. 3 at 2:33 PM

$GCTK nobody buying even at these levels. 10K volume and only small speed bumps to slow it down.. only one bull here?

0 · Reply

race2zero Feb. 3 at 2:15 PM

$GCTK where you at bulls? Can’t push up with this look?

0 · Reply

Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform

Dec 30, 2025, 8:00 AM EST - 5 weeks ago

Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor

Nov 13, 2025, 4:05 PM EST - 2 months ago

Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights

Nov 3, 2025, 4:05 PM EST - 3 months ago

Glucotrack, Inc. Encourages Shareholders to Vote

Oct 29, 2025, 4:05 PM EDT - 3 months ago

Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team

Oct 28, 2025, 8:00 AM EDT - 3 months ago

Glucotrack, Inc. Reminds Shareholders to Vote

Sep 11, 2025, 8:00 AM EDT - 5 months ago

Glucotrack to Participate in the Q3 Virtual Investor Summit

Aug 14, 2025, 4:05 PM EDT - 6 months ago

Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 6, 2025, 8:30 AM EDT - 6 months ago

Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology

Jul 31, 2025, 8:30 AM EDT - 6 months ago

Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting

Jul 8, 2025, 8:30 AM EDT - 7 months ago

Glucotrack Announces Repurchase of Series A Warrants

Jun 25, 2025, 10:40 AM EDT - 7 months ago

Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday?

Jun 25, 2025, 8:30 AM EDT - 7 months ago

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

Jun 12, 2025, 9:05 AM EDT - 8 months ago

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements

Jun 4, 2025, 8:30 AM EDT - 8 months ago

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions

May 28, 2025, 8:30 AM EDT - 8 months ago

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD

May 20, 2025, 8:30 AM EDT - 9 months ago

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development

May 14, 2025, 5:10 PM EDT - 9 months ago

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 13, 2025, 8:01 AM EDT - 9 months ago

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor

Apr 16, 2025, 8:00 AM EDT - 10 months ago

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas

Apr 3, 2025, 8:01 AM EDT - 10 months ago

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor

Mar 31, 2025, 5:00 PM EDT - 11 months ago

Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 19, 2025, 8:01 AM EDT - 11 months ago

Glucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes

Feb 26, 2025, 8:01 AM EST - 1 year ago

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member

Feb 4, 2025, 12:24 PM EST - 1 year ago

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Feb 4, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

Jan 29, 2025, 9:00 AM EST - 1 year ago

Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer

Jan 21, 2025, 8:01 AM EST - 1 year ago

Glucotrack Announces ISO 13485:2016 Certification

Jan 15, 2025, 8:01 AM EST - 1 year ago

Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs

Jan 7, 2025, 4:05 PM EST - 1 year ago

Glucotrack to Present at TechBio Showcase™ 2025

Dec 3, 2024, 8:30 AM EST - 1 year ago

GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR

Nov 14, 2024, 4:30 PM EST - 1 year ago

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt

Oct 22, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE

Oct 1, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING

Sep 3, 2024, 9:00 AM EDT - 1 year ago

JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

Aug 15, 2024, 9:00 AM EDT - 1 year ago

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

Aug 5, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE

Jun 20, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Jun 13, 2024, 9:19 AM EDT - 1 year ago

GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR

Jun 10, 2024, 10:50 AM EDT - 1 year ago

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE

Jun 5, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

May 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY

May 15, 2024, 4:15 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT

May 2, 2024, 9:00 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Apr 22, 2024, 2:10 PM EDT - 1 year ago

GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT

Apr 16, 2024, 8:30 AM EDT - 1 year ago

GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING

Apr 2, 2024, 8:30 AM EDT - 2 years ago

GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Mar 12, 2024, 9:30 AM EDT - 2 years ago

GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY

Feb 27, 2024, 8:30 AM EST - 2 years ago

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Feb 13, 2024, 9:30 AM EST - 2 years ago

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

race2zero Feb. 4 at 5:29 AM

$GCTK did you give up?

0 · Reply

race2zero Feb. 3 at 9:03 PM

$GCTK just a reminder people. Down 99.99% all time, picture perfect bio scam company with no future

0 · Reply

race2zero Feb. 3 at 8:58 PM

$GCTK better tell them to release the news, it’s headed under $1 if they don’t

0 · Reply

race2zero Feb. 3 at 7:31 PM

$GCTK all the bulls are gone!

0 · Reply

SorinC Feb. 3 at 7:23 PM

$GCTK where's this guy?told him he's an idiot and didn't believe me🤣 @JesseBullman

0 · Reply

PLATINUM_TRADES Feb. 3 at 6:41 PM

$GCTK Adds! Over $2.00 soon imo be patient 🚨🚨

0 · Reply

race2zero Feb. 3 at 5:12 PM

$GCTK seems to be going the wrong direction, again…

0 · Reply

race2zero Feb. 3 at 2:45 PM

$GCTK lots of green out there today and then there’s this…

1 · Reply

race2zero Feb. 3 at 2:33 PM

$GCTK nobody buying even at these levels. 10K volume and only small speed bumps to slow it down.. only one bull here?

0 · Reply

race2zero Feb. 3 at 2:15 PM

$GCTK where you at bulls? Can’t push up with this look?

0 · Reply

Bubi123 Feb. 3 at 10:35 AM

$GCTK ⭐️What happens to an implantable electrochemical glucose sensor over one year? ⭐️So TTP, in collaboration with Glucotrack measured the performance of variants of Glucotrack’s glucose oxidase-based electrochemical sensors over 12 months under controlled ageing conditions.

0 · Reply

PLATINUM_TRADES Feb. 3 at 1:25 AM

$GCTK Glucose always a winner who doesn't love the sugar.... Finally bouncing $2.19 was yesterday's high I'd like to see that break tomorrow🚨🚨

0 · Reply

MoneyFrogy Feb. 2 at 10:07 PM

$GCTK Reversal intact here Potential 2.5$+ easy

0 · Reply

Tradr1205 Feb. 2 at 8:28 PM

$GCTK Bought some more today! It'll rebound very soon....and in a big way!!

0 · Reply

Bubi123 Feb. 2 at 7:56 PM

$GCTK https://www.techrxiv.org/users/1011492/articles/1374482-year-long-measurement-of-glucose-oxidase-deactivation-in-electrochemical-glucose-sensors?utm_campaign=HT-BIOSENSING-brand-awareness&utm_content=518838486&utm_medium=social&utm_source=linkedin&hss_channel=lcp-122597

0 · Reply

Bubi123 Feb. 2 at 7:55 PM

$GCTK just saying when they annonce this will be bought its to late to take a place 🥰

1 · Reply

Bubi123 Feb. 2 at 7:43 PM

$GCTK 2 million ——> 200 million dollar worth when they start pivotal soon and BP step in 🤓😉🥰

0 · Reply

Bubi123 Feb. 2 at 7:36 PM

$GCTK

0 · Reply

MoneyFrogy Feb. 2 at 7:24 PM

$GCTK 800k floater Oversold Took some

0 · Reply

PsychedStocks Feb. 2 at 7:03 PM

$GCTK why did this dip? The patents seem pretty significant

1 · Reply

anonAlb Feb. 2 at 6:45 PM

$GCTK this week will be interesting 😎🫡💎💎💎

0 · Reply

race2zero Feb. 2 at 5:48 PM

$GCTK no bulls here today?

0 · Reply

Market Cap	1.74M
Revenue (ttm)	0.00
Net Income (ttm)	-22.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	1.19

Volume	156,000
Avg Vol	406,182
Day's Range	N/A - N/A
Shares Out	911,000.00
Stochastic %K	4%
Beta	0.33
Analysts	Strong Buy
Price Target	N/A